Trends in transcatheter and surgical aortic valve replacement in the United States, 2008-2018 - 26/11/21

Doi : 10.1016/j.ahj.2021.03.017

Katherine AA Clark, MD, MBA ^a,^{^{1
These authors contributed equally to this work}}, Fouad Chouairi, BS ^b,^{^{1
These authors contributed equally to this work}}, Bradley Kay, MD ^a, Samuel W Reinhardt, MD ^a, P Elliott Miller, MD ^a, Michael Fuery, MD ^c, Clancy W Mullan, MD ^d, Avirup Guha, MD ^e,^f, Tariq Ahmad, MD ^a,^g, Nihar R Desai, MD, MPH ^a,^g,^⁎
^a Division of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT
^b Yale University School of Medicine, New Haven, CT
^c Department of Internal Medicine, Yale University School of Medicine, New Haven, CT
^d Division of Cardiac Surgery, Yale University School of Medicine, New Haven, CT
^e Case Western Reserve University, Cleveland, OH
^f Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, OH
^g Center for Outcomes Research and Evaluation, New Haven, CT

^⁎Reprint requests: Nihar R Desai, MD, MPH, Center for Outcomes Research and Evaluation, 330 Cedar Street, New Haven, CT 06510Center for Outcomes Research and Evaluation,330 Cedar StreetNew HavenCT06510

Résumé

We conducted a retrospective study using the NIS database from 2008 to 2018 to examine the most contemporary national hospitalization trends of transcatheter (TAVR) and surgical (SAVR) aortic valve replacement regarding volume, patient and hospital demographics and economics, resource utilization, total cost of stay, and in-hospital mortality. We demonstrate that TAVR procedures have been performed on a slow by steadily diversifying patient population while volume has grown significantly, while in-hospital mortality, length of stay, discharge home, and costs have improved, whereas these metrics have generally remained stable for SAVR. These trends will likely drive continued TAVR adoption, greatly expanding the overall aortic stenosis patient population eligible for AVR.

Le texte complet de cet article est disponible en PDF.

Plan

Background

Materials and Methods

Data Source and Study Population

Statistical Methods

Funding, Research, and Creation

Credit Author Statement

Export

Vol 243

P. 87-91 - janvier 2022 Retour au numéro

Article précédent

Impact of vomiting on P2Y12 platelet inhibition in patients with ST-elevation myocardial infarction: A prespecified subanalysis of the ON-TIME 3 trial
Anne??H. Tavenier, Renicus??S. Hermanides, Jan??Paul. Ottervanger, Svetlana??V. Belitser, Olaf.??H. Klungel, Arnoud??W.J. van ‘t Hof, ON-TIME 3 investigators

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

connectez-vous ou créez un compte

Trends in transcatheter and surgical aortic valve replacement in the United States, 2008-2018 - 26/11/21

Résumé

Plan

Export citations

Fichier

Contenu

Accès rapides

Mon compte

Aide & support

Plateformes Elsevier Masson

Déclaration CNIL